Beksaroten: interakcje

Acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids . (etykieta leku Acytretyna, Przeciwwskazania)

Because of a potential drug-drug interaction, avoid gemfibrozil use with TARGRETIN [ see Drug Interactions (7) ]. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (etykieta leku Minocyklina, Ostrzeżenia i środki ostrożności)

Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (etykieta leku Tetracyklina, Ostrzeżenia)

Tretinoin capsules are contraindicated in patients with a known hypersensitivity to tretinoin capsules, any of its components, or other retinoids. (etykieta leku Tretynoina, Przeciwwskazania)

Patients with CTCL who have risk factors for pancreatitis (e.g., prior pancreatitis, uncontrolled hyperlipidemia, excessive alcohol consumption, uncontrolled diabetes mellitus, biliary tract disease, and medications known to increase triglyceride levels or to be associated with pancreatic toxicity) may be at greater risk for pancreatitis associated with TARGRETIN… (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (etykieta leku Chlorek wapnia, Interakcje z innymi lekami)

Patients with elevated vitamin A levels may be at increased risk. (etykieta leku Eleksakaftor + tezakaftor + iwakaftor, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Patients with elevated vitamin A levels may be at increased risk. (etykieta leku Iwakaftor, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor patients receiving XATMEP with other potential hepatotoxins (e.g., azathioprine, retinoids, and sulfasalazine) for possible signs of hepatotoxicity. (etykieta leku Metotreksat, Interakcje z innymi lekami)

The effect of ORLISTAT on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived vitamin K is not known at this time [see Clinical Pharmacology (12.3) , and Warnings and Precautions (5.1) ] . (etykieta leku Orlistat, Interakcje z innymi lekami)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Monitor and replace thyroid hormone if needed. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Hypoglycemia Risk in Patients with Diabetes Mellitus In patients using insulin, agents enhancing insulin secretion (e.g., sulfonylureas), or insulin sensitizers (e.g., thiazolidinedione class), based on the mechanism of action, TARGRETIN could enhance the action of these agents, resulting in hypoglycemia. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Atorvastatin was used in 48% (73/152) of patients with CTCL. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Atorvastatin was used in 48% (73/152) of patients with CTCL. (etykieta leku Beksaroten, Ostrzeżenia i środki ostrożności)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Vitamin A Based on a case report in one patient receiving combination therapy with all-trans-retinoid acid (an acid form of vitamin A) and fluconazole, central nervous system (CNS) related undesirable effects have developed in the form of pseudotumor cerebri, which disappeared after discontinuation of fluconazole treatment. (etykieta leku Flukonazol, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (etykieta leku Glukonian wapnia, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)